CLASS II Drug recall · Reported 18 Jan 2023 · FDA Enforcement Report

Rocuronium Bromide Injection, 50 mg/ (10 mg/mL) recalled

Nephron Sterile Compounding Center is recalling Rocuronium Bromide Injection, 50 mg/ (10 mg/mL), mL Pre-Filled Syringe, syringe, distributed nationwide in the US. The recall was initiated on 6 Jan 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: RC2011A, Exp. 2/22/2023
Quantity recalled38,830 syringes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0099-2023
FDA event ID
91450
Recalling firm
Nephron Sterile Compounding Center, West Columbia, SC
Classification
Class II
Status
Terminated
Recall initiated
6 Jan 2023
FDA classified
9 Jan 2023
Reported
18 Jan 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

6 Jan 2023Recall initiated by company
9 Jan 2023Classified by FDA+3 days
18 Jan 2023Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL), 5 x 5 mL Pre-Filled Syringe, 6 x 5 syringe carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th Street Extension, West Columbia, SC 29172, NDC: 69374-924-05

Where it was distributed

Nationwide in the USA.

Nationwide

Questions about this recall

Is Rocuronium Bromide Injection, 50 mg/ (10 mg/mL), mL Pre-Filled Syringe, syringe recalled?

Yes. Nephron Sterile Compounding Center recalled Rocuronium Bromide Injection, 50 mg/ (10 mg/mL), mL Pre-Filled Syringe, syringe on 6 Jan 2023. The recall is Class II and its status is Terminated. Recall number D-0099-2023.

Why was it recalled?

Lack of Assurance of Sterility

Which lots are affected?

Lot: RC2011A, Exp. 2/22/2023

Where was it sold?

Nationwide in the USA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Nephron Sterile Compounding Center

All 73

Other Rocuronium bromide recalls

All 6